Distinct morphophenotypic features of chronic B‐cell leukaemias identified with CDlc and CD23 antibodies
暂无分享,去创建一个
F. Rilke | G. Cattoretti | D. Delia | N. Polli | A. Orazi
[1] H. Gralnick,et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. , 1989, Journal of clinical pathology.
[2] M. Chilosi,et al. Cell-cell and cell-matrix adhesion structures may influence the growth pattern of chronic lymphoid malignancies. , 1989, Leukemia.
[3] L. Boumsell,et al. CD1 expression on B‐CLL lymphocytes , 1989, British journal of haematology.
[4] C. S. Scott,et al. Diagnostic differentiation of chronic B‐cell malignancies using monoclonal antibody L161 (CD1c) , 1989, British journal of haematology.
[5] G. Inghirami,et al. Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia , 1988 .
[6] M. Ratain,et al. Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique. , 1988, American journal of clinical pathology.
[7] G. Pinkus,et al. Circulating malignant cells in non-Hodgkin's lymphoma: correlation with binding by peanut agglutinin. , 1988, Blood.
[8] F. Rilke,et al. CD1c but neither CD1a nor CD1b molecules are expressed on normal, activated, and malignant human B cells: identification of a new B-cell subset. , 1988, Blood.
[9] D. Mason,et al. Expression of the interleukin-2 receptor (Tac antigen/CD25) in hematologic neoplasms. , 1988, American journal of clinical pathology.
[10] J. Cawley,et al. Heterogeneity of CLL: high CD23 antigen and αIFN receptor expression are features of favourable disease and of cell activation , 1988, British journal of haematology.
[11] B. Drewinko,et al. Flow cytochemical patterns of white blood cells in human haematopoietic malignancies: II, CHRONIC LEUKAEMIAS , 1987, British journal of haematology.
[12] H. Schuurman,et al. Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology. , 1987, The American journal of pathology.
[13] J. Melo,et al. Splenic B cell lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens. , 1987, Journal of clinical pathology.
[14] A. Berrebi,et al. Expression of B cell activation antigens on normal and malignant B cells. , 1987, Leukemia.
[15] F. Rilke,et al. Expression of the T1 (CD5, p67) surface antigen in B‐CLL and B‐NHL and its correlation with other B‐cell differentiation markers , 1986, Hematological oncology.
[16] D. Mason,et al. APAAP LABELLING OF BLOOD AND BONE-MARROW SAMPLES FOR PHENOTYPING LEUKAEMIA , 1986, The Lancet.
[17] A. Bousvaros,et al. Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience. , 1985, The American journal of pathology.
[18] D. Catovsky,et al. Normal counterparts of hairy cells and B-prolymphocytes in the peripheral blood. An ultrastructural study with monoclonal antibodies and the immunogold method. , 1985, Leukemia research.
[19] G. Den Ottolander,et al. Hairy cell leukemia: its place among the chronic B cell leukemias. , 1984, Seminars in oncology.
[20] H. Zola,et al. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes. , 1981, Journal of immunology.
[21] S. Lewis,et al. Cell Volume Studies in B‐Cell Leukaemia , 1980, British journal of haematology.